Influence of light fluence rate on the effects of photodynamic therapy in an orthotopic rat glioma model.

OBJECT Failure of treatment for high-grade gliomas is usually due to local recurrence at the site of resection, indicating that a more aggressive local therapy could be beneficial. Photodynamic therapy (PDT) is a local treatment involving the administration of a tumor-localizing photosensitizing drug, in this case aminolevulinic acid (ALA). The effect depends on the total light energy delivered to the target tissue, but may also be influenced by the rate of light delivery. METHODS In vitro experiments showed that the sensitivity to ALA PDT of BT4C multicellular tumor spheroids depended on the rate of light delivery (fluence rate). The BT4C tumors were established intracranially in BD-IX rats. Microfluorometry of frozen tissue sections showed that photosensitization is produced with better than 200:1 tumor/normal tissue selectivity after ALA injection. Four hours after intraperitoneal ALA injection (125 mg/kg), 26 J of 632 nm light was delivered interstitially over 15 (high fluence rate) or 90 (low fluence rate) minutes. Histological examination of animals treated 14 days after tumor induction demonstrated extensive tumor necrosis after low-fluence-rate PDT, but hardly any necrosis after high-fluence-rate treatment. Neutrophil infiltration in tumor tissue was increased by PDT, but was similar for both treatment regimens. Low-fluence-rate PDT administered 9 days after tumor induction resulted in statistically significant prolongation of survival for treated rats compared with nontreated control animals. CONCLUSIONS Treatment with ALA PDT induced pronounced necrosis in tumors only if the light was delivered at a low rate. The treatment prolonged the survival for tumor-bearing animals.

[1]  L. Lilge,et al.  Photodynamic therapy of intracranial tissues: a preclinical comparative study of four different photosensitizers. , 1998, Journal of clinical laser medicine & surgery.

[2]  A H Kaye,et al.  Photodynamic therapy of brain tumors. , 1996, Seminars in surgical oncology.

[3]  T. Hasan,et al.  In vivo fluence rate and fractionation effects on tumor response and photobleaching: photodynamic therapy with two photosensitizers in an orthotopic rat tumor model. , 1999, Cancer research.

[4]  Bruce J. Tromberg,et al.  Repetitive 5-aminolevulinic acid-mediated photodynamic therapy on human glioma spheroids , 2003, Journal of Neuro-Oncology.

[5]  W. Rachinger,et al.  Oedema formation in experimental photo-irradiation therapy of brain tumours using 5-ALA , 2004, Acta Neurochirurgica.

[6]  W. Star,et al.  Light dosimetry in vivo. , 1997, Physics in medicine and biology.

[7]  T J Dougherty,et al.  2‐[1‐hexyloxyethyl]‐2‐devinyl pyropheophorbide‐a (HPPH) in a nude rat glioma model: Implications for photodynamic therapy , 2001, Lasers in surgery and medicine.

[8]  Bernhard Olzowy,et al.  Photoirradiation therapy of experimental malignant glioma with 5-aminolevulinic acid. , 2002, Journal of neurosurgery.

[9]  Steen J. Madsen,et al.  Repetitive 5-aminolevulinic acid mediated photodynamic therapy of rat glioma , 2004, SPIE BiOS.

[10]  J Moan,et al.  5‐Aminolevulinic acid‐based photodynamic therapy , 1997, Cancer.

[11]  K. Haglid,et al.  Phenotypic properties of neoplastic cell lines developed from fetal rat brain cells in culture after exposure to ethylnitrosourea in vivo , 1977, Zeitschrift für Krebsforschung und Klinische Onkologie.

[12]  T. Foster,et al.  Oxygen consumption and diffusion effects in photodynamic therapy. , 1991, Radiation research.

[13]  Brian C. Wilson,et al.  Photofrin photodynamic therapy for malignant brain tumors , 2001, SPIE BiOS.

[14]  Alison Curnow,et al.  Light Dose Fractionation to Enhance Photodynamic Therapy Using 5‐Aminolevulinic Acid in the Normal Rat Colon , 1999, Photochemistry and photobiology.

[15]  Steen J. Madsen,et al.  Interstitial light application for photodynamic therapy in a rat brain tumor model , 2004, SPIE BiOS.

[16]  Stanley B. Brown,et al.  Protoporphyrin IX Fluorescence Photobleaching during ALA‐Mediated Photodynamic Therapy of UVB‐Induced Tumors in Hairless Mouse Skin , 1999, Photochemistry and photobiology.

[17]  H. J. van Staveren,et al.  Photodynamic therapy for esophageal lesions: selectivity depends on wavelength, power, and light dose. , 1999, The Annals of thoracic surgery.

[18]  B. Tromberg,et al.  Development of a novel indwelling balloon applicator for optimizing light delivery in photodynamic therapy , 2001, Lasers in surgery and medicine.

[19]  H. V. Herck,et al.  Recommendations for the health monitoring of mouse, rat, hamster, guineapig and rabbit breeding colonies: Report of the Federation of European Laboratory Animal Science Associations (FELASA) Working Group on Animal Health accepted by the FELASA Board of Management November 1992 , 1994, Laboratory animals.

[20]  S. K. Powers,et al.  IMPROVED SURVIVAL FROM INTRACAVITARY PHOTODYNAMIC THERAPY OF RAT GLIOMA , 1992, Photochemistry and photobiology.

[21]  Henry Brem,et al.  Recent Advances in Brain Tumor Therapy: Local Intracerebral Drug Delivery by Polymers , 2004, Investigational New Drugs.

[22]  A. Obwegeser,et al.  Uptake and kinetics of 14C-labelled meta-tetrahydroxyphenylchlorin and 5-aminolaevulinic acid in the C6 rat glioma model. , 1998, British Journal of Cancer.

[23]  Lothar Lilge,et al.  Metronomic Photodynamic Therapy as a New Paradigm for Photodynamic Therapy: Rationale and Preclinical Evaluation of Technical Feasibility for Treating Malignant Brain Tumors¶ , 2004, Photochemistry and photobiology.

[24]  Barbara W. Henderson,et al.  Choice of Oxygen-Conserving Treatment Regimen Determines the Inflammatory Response and Outcome of Photodynamic Therapy of Tumors , 2004, Cancer Research.

[25]  A. E. Saarnak,et al.  5-Aminolevulinic Acid Induced Endogenous Porphyrin Fluorescence in 9L and C6 Brain Tumours and in the Normal Rat Brain , 1998, Acta Neurochirurgica.

[26]  Bruce J. Tromberg,et al.  ALA- and ALA-ester-mediated Photodynamic Therapy of Human Glioma Spheroids , 2002, Journal of Neuro-Oncology.

[27]  H Stepp,et al.  Fluorescence-guided resection of glioblastoma multiforme by using 5-aminolevulinic acid-induced porphyrins: a prospective study in 52 consecutive patients. , 2000, Journal of neurosurgery.

[28]  A. Torvik,et al.  Uptake of plasma proteins into damaged neurons , 1991, Acta Neuropathologica.

[29]  A. Curnow,et al.  Spatial measurement of oxygen levels during photodynamic therapy using time-resolved optical spectroscopy. , 1998, Journal of photochemistry and photobiology. B, Biology.

[30]  H Stepp,et al.  Intraoperative detection of malignant gliomas by 5-aminolevulinic acid-induced porphyrin fluorescence. , 1998, Neurosurgery.

[31]  Henry Hirschberg,et al.  Effects of Combined Photodynamic Therapy and Ionizing Radiationon Human Glioma Spheroids¶ , 2002, Photochemistry and photobiology.

[32]  D. Kessel,et al.  An apoptotic response to photodynamic therapy with endogenous protoporphyrin in vivo. , 1996, Journal of photochemistry and photobiology. B, Biology.

[33]  H. Hirschberg,et al.  Intracavity Fractionated Balloon Brachytherapy in Glioblastoma , 1999, Acta Neurochirurgica.

[34]  V. Wallace,et al.  Photodynamic Therapy of Human Glioma Spheroids Using 5-Aminolevulinic Acid¶ , 2000, Photochemistry and photobiology.

[35]  H. Hirschberg,et al.  Growth of precultured human glioma specimens in nude rat brain. , 1999, Journal of neurosurgery.

[36]  L. Lilge,et al.  Apoptosis induced in vivo by photodynamic therapy in normal brain and intracranial tumour tissue , 2000, British Journal of Cancer.

[37]  P. Iversen,et al.  Combination of E of Enddostatin and a Protein Kinase Cα DNA Enzyme Improves the Survival of Rats with Malignant Glioma , 2002 .

[38]  W. Stummer,et al.  In vitro and in vivo porphyrin accumulation by C6 glioma cells after exposure to 5-aminolevulinic acid. , 1998, Journal of photochemistry and photobiology. B, Biology.

[39]  J. Tulip,et al.  Photoradiation therapy: current status and applications in the treatment of brain tumors. , 1986, Surgical neurology.

[40]  K. Wallner,et al.  Patterns of failure following treatment for glioblastoma multiforme and anaplastic astrocytoma. , 1989, International journal of radiation oncology, biology, physics.

[41]  R. Goldbrunner,et al.  Models for Assessment of Angiogenesis in Gliomas , 2000, Journal of Neuro-Oncology.